Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) have earned an average rating of “Hold” from the ten ratings firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $15.64.

A number of research firms have recently weighed in on CCRN. Credit Suisse Group began coverage on Cross Country Healthcare in a report on Tuesday, November 7th. They set a “neutral” rating and a $13.00 price target for the company. TheStreet cut Cross Country Healthcare from a “b-” rating to a “c+” rating in a report on Friday, November 3rd. BMO Capital Markets lowered their price target on Cross Country Healthcare from $15.00 to $14.00 and set an “outperform” rating for the company in a report on Monday, November 6th. Cantor Fitzgerald reiterated a “buy” rating and set a $18.00 price target on shares of Cross Country Healthcare in a report on Wednesday, November 1st. Finally, Zacks Investment Research cut Cross Country Healthcare from a “hold” rating to a “sell” rating in a report on Monday, October 9th.

Cross Country Healthcare (NASDAQ CCRN) traded down $0.64 during midday trading on Monday, hitting $13.54. The stock had a trading volume of 133,592 shares, compared to its average volume of 232,617. The stock has a market cap of $505.63, a PE ratio of 22.16, a PEG ratio of 1.26 and a beta of 0.73. The company has a current ratio of 2.14, a quick ratio of 2.14 and a debt-to-equity ratio of 0.46. Cross Country Healthcare has a fifty-two week low of $11.07 and a fifty-two week high of $16.38.

Cross Country Healthcare (NASDAQ:CCRN) last released its quarterly earnings results on Wednesday, November 1st. The business services provider reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The business had revenue of $228.50 million during the quarter, compared to analysts’ expectations of $228.97 million. Cross Country Healthcare had a return on equity of 11.69% and a net margin of 0.19%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.24 EPS. analysts expect that Cross Country Healthcare will post 0.64 EPS for the current fiscal year.

In other news, Director Thomas C. Dircks bought 10,000 shares of the stock in a transaction that occurred on Monday, November 6th. The stock was bought at an average cost of $11.77 per share, for a total transaction of $117,700.00. Following the acquisition, the director now directly owns 104,571 shares of the company’s stock, valued at approximately $1,230,800.67. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Susan E. Ball sold 25,000 shares of the firm’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $14.19, for a total value of $354,750.00. Following the transaction, the general counsel now owns 126,921 shares of the company’s stock, valued at $1,801,008.99. The disclosure for this sale can be found here. Company insiders own 3.90% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. BNP Paribas Arbitrage SA boosted its holdings in Cross Country Healthcare by 57.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,998 shares of the business services provider’s stock valued at $129,000 after acquiring an additional 3,660 shares during the period. FDx Advisors Inc. purchased a new position in shares of Cross Country Healthcare in the 3rd quarter valued at about $146,000. Strs Ohio boosted its stake in shares of Cross Country Healthcare by 69.5% in the 3rd quarter. Strs Ohio now owns 16,100 shares of the business services provider’s stock valued at $229,000 after buying an additional 6,600 shares during the period. Stevens Capital Management LP purchased a new position in shares of Cross Country Healthcare in the 3rd quarter valued at about $249,000. Finally, Voya Investment Management LLC boosted its stake in shares of Cross Country Healthcare by 16.9% in the 2nd quarter. Voya Investment Management LLC now owns 18,329 shares of the business services provider’s stock valued at $237,000 after buying an additional 2,646 shares during the period. Institutional investors own 92.13% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/12/11/cross-country-healthcare-inc-ccrn-receives-average-rating-of-hold-from-analysts.html.

About Cross Country Healthcare

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.